Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 5,170 |
| Marketable Securities | 24,230 |
| Other current assets | 720 |
| TOTAL | $30,120 |
| Non-Current Assets | |
| Other Non-Current Assets | 50 |
| TOTAL | $50 |
| Total Assets | $31,470 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 1,390 |
| Accrued Expenses | 2,060 |
| Other current liabilities | 750 |
| TOTAL | $4,210 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 83,630 |
| TOTAL | $83,630 |
| Total Liabilities | $87,840 |
| Shareholders' Equity | |
| Common Shares | 2 |
| Retained earnings | -62,010 |
| Other shareholders' equity | -2,782 |
| TOTAL | $-56,370 |
| Total Liabilities And Equity | $31,470 |